View Latest Medical and Pharma Bids and Tenders

Supply of vaccine and Medicines

Supply of Production of compatible & High Quality Animal vaccine Locally Substitution of vaccine import (Chemicals,Reagents, Media,,Glassware, Laboratory Consumables,Laboratory Equipment & pharmacy item)

Supply of FMD Vaccine Production Project (Chemicals,Reagents,Media, ,Glassware, Laboratory Consumables, Laboratory Equipment & pharmacy item)

Supply of Medicine and Medical / Surgical equipments : Auto - Disable Syringe, 5ml for\nreconstitutions of vaccine.\nGeneral Characteristics: Single-use,\nSterile, Including mechanism to\nprevent reuse.\nMaterial: Polypropylene.\nSyringe size with pre-set volume and\nsingle marking 5ml\nNeedle: Diameter 21 G (0.6mm),\nLength 40mm (1 1/2")\nEach Syringe with permanently\nattached needle and should be packed\nBlister or Ribbon pack.\nNeedle cap and cap over thumb plate\n(If applicable) make Syringe into a\nsterile unit.\nShelf life remaining minimum of 3/4 of\nthe life time at the time of delivery.\nRequirements should confirm to WHO\nperformance specification E8/DS 1\nand ISO quality system standard\n7886-3\nOffers should be only from WHO pre-\nqualified AD Syringe suppliers\nrecommended by World Health\nOrganization (WHO) for\nbulk purchase for the U.N. agencies.\nPacking size: 100 Syringes per box.\nAD Syringes should be packed\naccording to the WHO and ISO\nguidelines on packaging for\ninternational shipping. etc .

Supply of Medicine and Medical / Surgical equipments : Auto - Disable Syringe, 5ml for\nreconstitutions of vaccine.\nGeneral Characteristics: Single-use,\nSterile, Including mechanism to\nprevent reuse.\nMaterial: Polypropylene.\nSyringe size with pre-set volume and\nsingle marking 5ml\nNeedle: Diameter 21 G (0.6mm),\nLength 40mm (1 1/2")\nEach Syringe with permanently\nattached needle and should be packed\nBlister or Ribbon pack.\nNeedle cap and cap over thumb plate\n(If applicable) make Syringe into a\nsterile unit.\nShelf life remaining minimum of 3/4 of\nthe life time at the time of delivery.\nRequirements should confirm to WHO\nperformance specification E8/DS 1\nand ISO quality system standard\n7886-3\nOffers should be only from WHO pre-\nqualified AD Syringe suppliers\nrecommended by World Health\nOrganization (WHO) for\nbulk purchase for the U.N. agencies.\nPacking size: 100 Syringes per box.\nAD Syringes should be packed\naccording to the WHO and ISO\nguidelines on packaging for\ninternational shipping. etc .

Supply of Medicine and Medical / Surgical equipments : 30,000 vials of MMR Vaccine 10\ndose vial (with a suitable diluent) etc .

Supply of Medicine and Medical / Surgical equipments : Tetanus Toxoid Adsorbed 0.5ml (single\ndose) Ampoule/vial\nAdsorbed Tetanus Vaccine BP single dose\n(0.5mL)\nOR\nTetanus Toxoid Adsorbed USP single dose\n(0.5mL)\nEach 0.5mL single dose ampoule/vial should\ncontain an estimated potency of not less than\n40 units of Tetanus Toxoid. The vaccine to\ncontain Tetanus Toxoid produced by the\ngrowth of Clostridum Tetani in the form of\nTetanus Formol Toxoid.\nNote:\n1. Offers should be only from vaccine suppliers\nrecommended by World Health Organization\nfor bulk purchase for U.N. Agencies (WHO pre-\nqualified).\n2. The following documents should be\nsubmitted pre- shipment for each lot of vaccine\ndispatched. (a)Invoice (b) Certificate of origin\n(c) Certificate of analysis (d)Lot release\ncertificate from National control\nLaboratory(NCL) from country of\norigin.(e)Summary lot protocols of production\nprocedure & quality control testing. These\ndocuments should be submitted pre-shipment\nto the National Control Laboratory for Vaccines\n(MRI) Sri Lanka.\n3. The product should be from fresh stocks and\neach consignment should be prepared\npreferably from a single batch.\n4. The product should have a minimum 2/3 of\nremaining shelf life at the time of delivery at\nMSD.\n5. The vaccine should also comply with the\ngeneral requirements for vaccines in the\nBP,USP or other pharmacopeial standards\napproved by NMRA, Sri Lanka.\n6. Cold Chain monitors or WHO recommended\nother cold chain monitoring device should be\nincluded for each carton and the cold chain etc .

Supply of Medicine and Medical / Surgical equipments : Bacillus Calmette-Guerin Vaccine (BCG) 20\ndose vial (with a suitable diluent)\nBacillus Calmette-Guerin vaccine (BCG) 20\ndose Vial\nBacillus Calmette-Guerin vaccine BP or USP\n(BCG Vaccine)\nEach infant (<1 year old) dose should contain\n0.025mg of live Bacillus Calmette - Guerin and\nwhen reconstituted, the dose should be 0.05mL\n1.Offers should be only from vaccine suppliers\nrecommended by World Health Organization\n(WHO) for bulk purchase for the UN Agencies.\n2. The product should be from fresh stocks\nand each consignment should be prepared\npreferably from a single batch. Each batch\nshould accompany a certificate of analysis, lot\nrelease certificate issued by a laboratory\naccredited by National Control Authority and\nSummary Protocol of vaccine production and\nquality control test data should be submitted for\nprotocol review.\n3. Each consignment should have a minimum\nremaining shelf life of 75% at the time of\nreceiving the consignment at MSD.\n4. The vaccine should also comply with the\ngeneral requirements for vaccines in the BP or\nUSP.\n5. The vaccine should meet the most recent\nrequirements of WHO when tested by the\nmethods outlined by WHO.\n6. Vaccine should be stored at a temperature\nof 2'C-8'C. Cold chain monitors or WHO\nrecommended other cold chain monitoring\ndevice should be included in each pack during\ndelivery and the cold chain should be\nmaintained during storage, transport and\ndelivery of vaccines.\n7. Each vial to be provided with a suitable\nsterile diluent.\n8. Each vial should contain a suitable vaccine\nvial monitor.\n9. Must be a WHO prequalified product. etc .

Supply of Medicine and Medical / Surgical equipments : Adsorbed Diphtheria and Tetanus\nVaccine (DT) 10 dose vial\nAdsorbed Diphtheria and Tetanus\nVaccine(DT),10 dose vial. Adsorbed\nDiphtheria and Tetanus Vaccine BP or USP.\nEach 0.5ml single dose containing not less\nthan 30 international units (IU) of Diphtheria\nToxoid and not less than 40 IU of Tetanus\nToxoid.\ni.Offers should be only from vaccine\nsuppliers recommended by World Health\nOrganization (WHO) for bulk purchase for\nthe U.N. Agencies.\nii.The product should be from fresh stocks\nand each consignment should be prepared\npreferably from a single batch. Each batch\nshould accompany a certificate of analysis,\nlot release certificate issued by a laboratory\naccredited by National Control Authority and\nSummary Protocol of vaccine production\nand quality control test data should be\nsubmitted for protocol review.\niii.Each consignment should have a\nminimum remaining shelf life of 75% at the\ntime of receiving the consignment at MSD.\niv.The vaccine should also comply with the\ngeneral requirements for vaccines in the BP\nor USP.\nv.The vaccine should meet the most recent\nrequirements of WHO when tested by the\nmethods outlined by WHO.\nvi.Cold chain monitors or WHO\nrecommended other cold chain monitoring\ndevice should be included in each pack\nduring delivery and the cold chain should be\nmaintained during storage, transport and\ndelivery of vaccines.\nvii.The vaccine should be protected from\nlight and should be stored at a temperature\n+2'C to +8'C. Vaccines should not be frozen.\nviii.Each vial should be labeled accordingly\nindicating both date of manufacture and\nexpiry.\nix.Must be a WHO prequalified product.\nx.Each vial should contain a suitable vaccine\nvial monitor. etc .

Supply of Medicine and Medical / Surgical equipments : Bivalent Poliomyelitis Vaccine Live 10\ndose vial (with a suitable dropper)\nBivalent Poliomyelitis Vaccine Live Oral\n(bOPV)10 dose vial Bivalent Poliomyelitis\nVaccine Live BP,EP or USP Liquid stabilized\npreparation of live attenuated poliomyelitis\nvirus of the Sabin strains type 1 and type 3.\nEach immunizing dose of vaccine should\ncontain not less than 10 6 TCID50 for type 1\nand 10 5.8 TCID50 for type 3 (should\nconform to the formulation of ratio of 10:6 for\nvaccine virus sero type 1 and 3\nrespectively). One immunizing dose should\nbe contained preferably in two drops.\ni.Offers should be only from vaccine\nsuppliers recommended by World Health\nOrganization (WHO) for bulk purchase for\nthe U.N. Agencies.\nii.The product should be from fresh stocks\nand each consignment should be prepared\npreferably from a single batch. Each batch\nshould accompany a certificate of\nanalysis,lot release certificate issued by\nlaboratory accredited by National Control\nAuthority and Summary Protocol of vaccine\nproduction and quality control test data\nshould be submitted for protocol review.\niii.Each consignment should have a minimu\nm remaining shelf life of 75% at the time of r\neceiving the consignment at MSD.\niv.The vaccine should also comply with the\ngeneral requirements for vaccines in the\nBP,EP or USP.\nv.The vaccine should meet the most recent\nrequirements of WHO when tested by the\nmethods outlined by WHO.\nvi.Cold chain monitors or WHO\nrecommended other cold chain monitoring\ndevice should be included in each pack\nduring delivery and the cold chain should be\nmaintained during storage, transport and\ndelivery of vaccines.\nvii.The vaccine should be protected from\nlight and should be stored at a temperature -\n20'C. etc .